VIRIDIAN PHARMA

viridian-pharma-logo

Viridian Pharma, now part of Martindale Pharma, was established in the UK in 2002 to develop and market niche pharmaceutical products for hospital use.

#SimilarOrganizations #Website #More

VIRIDIAN PHARMA

Industry:
Health Care Pharmaceutical

Founded:
2002-01-01

Address:
Newport, Newport, United Kingdom

Country:
United Kingdom

Website Url:
http://www.viridianpharma.co.uk

Status:
Active

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Font Awesome Mobile Non Scaleable Content Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS


Similar Organizations

not_available_image

Auralis

Auralis developed generic pharmaceutical products for niche markets.

not_available_image

EuPharmed

EuPharmed is develops and markets pharmaceutical products.

not_available_image

Primegen

Primegen is develops pharmaceuticals products.

Official Site Inspections

http://www.viridianpharma.co.uk

  • Host name: 80.87.10.15
  • IP address: 80.87.10.15
  • Location: United Kingdom
  • Latitude: 51.4964
  • Longitude: -0.1224
  • Timezone: Europe/London

Loading ...

More informations about "Viridian Pharma"

Viridian - Framing the future of autoimmune diseases

Viridian Therapeutics is leveraging core expertise in antibody discovery to develop optimized treatments for rare autoimmune conditionsSee details»

Viridian Pharma - Crunchbase Company Profile & Funding

Viridian Pharma, now part of Martindale Pharma, was established in the UK in 2002 to develop and market niche pharmaceutical products for hospital use.See details»

VIRIDIAN PHARMA LIMITED - Companies House

VIRIDIAN PHARMA LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business...See details»

Viridian Therapeutics, Inc. - Investors & Media

Sep 11, 2024 · Viridian is a biopharmaceutical company focused on engineering and developing potential best-in-class medicines for patients with serious and rare diseases.See details»

Viridian Pharma - PitchBook

Developer and marketer of pharmaceutical products in Newport, United Kingdom. The company offers injectables, pre-filled syringes, oral products, ophthalmic drops and ointments for hospital use and healthcare professionals. Want …See details»

Our Company - Viridian Therapeutics, Inc.

At Viridian Therapeutics, we are focused on developing best-in-class medicines for people living with autoimmune and rare diseases. Leveraging our team’s expertise in antibody discovery and engineering, we have created a robust …See details»

Viridian Therapeutics, Inc. | LinkedIn

Viridian is a biopharmaceutical company focused on engineering and developing potential best-in-class medicines for patients with serious and rare diseases.See details»

Viridian Pharma Ltd.: Drug pipelines, Patents, Clinical trials - Synapse

Aug 24, 2023 · Explore Viridian Pharma Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»

VIRIDIAN PHARMA LIMITED Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for VIRIDIAN PHARMA LIMITED of ROMFORD. Get the latest business insights from Dun & Bradstreet.See details»

Viridian Therapeutics, Inc. - Viridian Therapeutics Highlights …

Feb 27, 2024 · WALTHAM, Mass.-- (BUSINESS WIRE)-- Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in …See details»

Viridian Therapeutics, Inc. - Viridian Announces Positive Data from ...

Jul 10, 2023 · Viridian plans to initiate the THRIVE-2 Phase 3 trial to evaluate the safety and efficacy of VRDN-001 in patients with chronic TED in the third quarter of 2023. The Company …See details»

miRagen Therapeutics Announces Company Name Change to …

Jan 19, 2021 · Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian’s most …See details»

Patient Community - Viridian Therapeutics, Inc.

Viridian is focused on engineering and developing potential best-in-class medicines for people living with autoimmune and rare diseases.See details»

miRagen Therapeutics Announces Company Name Change to …

Jan 19, 2021 · Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian’s most …See details»

miRagen Therapeutics Announces Company Name Change to …

Jan 19, 2021 · PDF Version Jonathan Violin, Ph.D., M.B.A. appointed President, CEO and director Barrett Katz , M.D., M.B.A. joins Viridian as Chief Medical Officer Viridian is …See details»

Viridian eye disease phase 3 hits, advancing push to rival Amgen

Sep 10, 2024 · Viridian Therapeutics’ phase 3 thyroid eye disease (TED) clinical trial has hit its primary and secondary endpoints. But with Amgen’s Tepezza already on the market, the data …See details»

VIRIDIAN PHARMA LIMITED - Companies House

VIRIDIAN PHARMA LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business …See details»

Viridian Therapeutics Reports 2020 Financial Results and Provides ...

BOULDER, Colo., March 25, 2021 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company advancing new treatments for patients suffering from …See details»

Viridian Announces Positive Data from Ongoing Phase 1/2

Nov 14, 2022 · Earlier this year, Viridian initiated a first-in-human Phase 1 clinical trial of VRDN-002, a novel monoclonal antibody that incorporates half-life extension technology and is …See details»

miRagen Therapeutics Announces Company Name Change to

Jan 19, 2021 · Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian’s most …See details»

linkstock.net © 2022. All rights reserved